BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26109676)

  • 1. No Benefit to Delaying Pneumococcal Polysaccharide Vaccination in HIV-Positive Adults.
    Leggat DJ; Iyer AS; Westerink MA
    J Infect Dis; 2015 Dec; 212(11):1851-2. PubMed ID: 26109676
    [No Abstract]   [Full Text] [Related]  

  • 2. 23-Valent Pneumococcal Polysaccharide Vaccine Uptake in the United States Air Force HIV Program.
    Ocampo TF; Le T; Matthews PE; Okulicz JF
    J Int Assoc Provid AIDS Care; 2016 Jul; 15(4):286-90. PubMed ID: 27215560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal immunization in immunocompromised hosts: where do we stand?
    Cordonnier C; Averbuch D; Maury S; Engelhard D
    Expert Rev Vaccines; 2014 Jan; 13(1):59-74. PubMed ID: 24308578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine.
    Glesby MJ; Watson W; Brinson C; Greenberg RN; Lalezari JP; Skiest D; Sundaraiyer V; Natuk R; Gurtman A; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B
    J Infect Dis; 2015 Jul; 212(1):18-27. PubMed ID: 25395187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization.
    Cohen AL; Harrison LH; Farley MM; Reingold AL; Hadler J; Schaffner W; Lynfield R; Thomas AR; Campsmith M; Li J; Schuchat A; Moore MR;
    AIDS; 2010 Sep; 24(14):2253-62. PubMed ID: 20671543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulating Evidence for Pneumococcal Conjugate Vaccination Among HIV-Infected Adults.
    Crum-Cianflone NF; Wallace MR
    J Infect Dis; 2015 Jul; 212(1):1-4. PubMed ID: 25395186
    [No Abstract]   [Full Text] [Related]  

  • 7. Pneumococcal vaccination in people living with HIV.
    Thornhill J; Sivaramakrishnan A; Orkin C
    Vaccine; 2015 Jun; 33(28):3159-60. PubMed ID: 25128803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing incidence of invasive pneumococcal disease and pneumonia despite improved vaccination uptake: surveillance in Hull and East Yorkshire, UK, 2002-2009.
    Elston JW; Santaniello-Newton A; Meigh JA; Harmer D; Allgar V; Allison T; Richardson G; Meigh R; Palmer SR; Barlow G
    Epidemiol Infect; 2012 Jul; 140(7):1252-66. PubMed ID: 22040368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Universal pneumococcal vaccination for India.
    Mathew JL
    Indian Pediatr; 2008 Feb; 45(2):160-1. PubMed ID: 18310801
    [No Abstract]   [Full Text] [Related]  

  • 10. What do the next 100 years hold for pneumococcal vaccination?
    Rijkers GT; van Mens SP; van Velzen-Blad H
    Expert Rev Vaccines; 2010 Nov; 9(11):1241-4. PubMed ID: 21087102
    [No Abstract]   [Full Text] [Related]  

  • 11. Protecting children with HIV against pneumococcal disease.
    Meehan A; Mackenzie G; Shingadia D; Booy R
    Lancet Infect Dis; 2009 Jul; 9(7):394-5. PubMed ID: 19555896
    [No Abstract]   [Full Text] [Related]  

  • 12. Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine.
    Yildirim I; Shea KM; Pelton SI
    Infect Dis Clin North Am; 2015 Dec; 29(4):679-97. PubMed ID: 26610421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to commentaries.
    Light DW
    Hum Vaccin; 2011 May; 7(5):496. PubMed ID: 21552005
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
    Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T
    Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe.
    Reinert RR; Paradiso P; Fritzell B
    Expert Rev Vaccines; 2010 Mar; 9(3):229-36. PubMed ID: 20218848
    [No Abstract]   [Full Text] [Related]  

  • 16. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Advisory Committee on Immunization Practices
    MMWR Recomm Rep; 2000 Oct; 49(RR-9):1-35. PubMed ID: 11055835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsonic function of bronchoalveolar lavage IgG after pneumococcal vaccination in HIV-infected and uninfected adults.
    Tam JC; Grant NL; Freire-Moran L; Tolmie H; French N; Gordon SB
    J Allergy Clin Immunol; 2009 Jun; 123(6):1420-1. PubMed ID: 19423153
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of serologic responses to vaccination with one dose or two doses of 7-valent pneumococcal conjugate vaccine in HIV-infected adult patients.
    Lu CL; Hung CC; Chuang YC; Liu WC; Su CT; Hsiao CF; Tseng YT; Su YC; Chang SF; Chang SY; Chang SC
    Vaccine; 2012 May; 30(24):3526-33. PubMed ID: 22484349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Splenectomy and pneumococcal vaccination].
    Jeurissen A
    Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1142-3; author reply 1143. PubMed ID: 12822528
    [No Abstract]   [Full Text] [Related]  

  • 20. Conjugate and polysaccharide pneumococcal vaccines do not improve initial response of the polysaccharide vaccine in HIV-infected adults.
    PeƱaranda M; Payeras A; Cambra A; Mila J; Riera M;
    AIDS; 2010 May; 24(8):1226-8. PubMed ID: 20299956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.